Cargando…
IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
Fifty million lymphokine‐activated killer (LAK) cells were infused into rat T9 gliosarcoma tumors for 1 hr at an infusion rate of 0.1 ml/hr. Cultured normal spleen cells were infused into similar tumors as a control. The LAK cell‐treated tumors began to regress at approximately 3 weeks after infusio...
Autores principales: | Yamaki, Toshiaki, Ibayashi, Yukihiro, Nakamura, Toru, Shubo, Noriharu, Daibo, Masahiko, Kawahara, Takahisa, Hashi, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917609/ https://www.ncbi.nlm.nih.gov/pubmed/3141326 http://dx.doi.org/10.1111/j.1349-7006.1988.tb00053.x |
Ejemplares similares
-
The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990) -
A New Form of Specific Targeting Cancer Immunotherapy Using Anti‐tumor Monoclonal Antibody‐conjugated Lymphokine‐activated Killer Cells
por: Shiraiwa, Hiroshi, et al.
Publicado: (1991) -
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990) -
Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986) -
Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)